Platelet Rich Plasma Versus Corticosteroids in Hip Osteoarthritis Pain

This study is comparing two treatments for hip osteoarthritis (OA) pain: Platelet Rich Plasma (PRP) and a corticosteroid injection (Kenalog and Xylocaine). Researchers want to see which treatment better reduces pain and improves function for people with hip OA. You might be able to join if you are between 21 and 80 years old, have a specific type of hip OA (Kellgren-Lawrence grade II or III), and are scheduled for a hip injection to treat your symptoms. The study will measure your pain levels at the start, then again at six weeks and three months after treatment to see how well each treatment works. The current recruitment status is unclear.

Study design: This is a randomized, single-blind study comparing two treatments for hip osteoarthritis pain. It plans to enroll 54 participants.
What's involved: You would receive either a Platelet Rich Plasma Joint Injection or a Corticosteroid Injection. Your pain levels will be measured at baseline, six weeks, and three months.
Compensation: Not stated in the trial record.
Follow-up: Participants will be followed for three months after treatment to assess pain scores.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

Platelet Rich Plasma Versus Corticosteroids in Hip Osteoarthritis Pain

Recruiting

PHASE4Ages 21–80InterventionalTreatment

LifeBridge Health

~54 participants

Updated 2025-03-14 on ClinicalTrials.gov

What's tested:Platelet Rich Plasma Joint InjectionCorticosteroid Injection

At a glance

Recruiting sites

1 of 1 listed site is recruiting right now

RecruitingSuspended, closed, or not yet open

What they're measuring

Pain Score VAS

Measured over baseline, six weeks, and three months

Conditions

Hip Osteoarthritis

NCT06793982

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

Sinai Hospital of Baltimore
Baltimore, Marylandstudy coordinator listed
Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Who to contact

Martin Gesheff, DHSc

[email protected]

410-601-9467

Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime

Eligibility criteria

Inclusion

Provision of signed and dated informed consent form

Stated willingness to comply with all study procedures and availability for the duration of the study

Male or female, aged 21-80 years

Radiographic diagnosis of Kellgren-Lawrence (KL) grade of II or III Hip osteoarthritis

Indicated for a Hip injection to treat Hip OA symptoms

Exclusion

Any injections into the target Hip within three months

Current overlying skin infection

Current or previous diagnosis of "chronic pain"

Opioid tolerant at time of screening (for a week or longer, at least 60 mg of morphine daily, or at least 30 mg of oral oxycodone daily, or at least 8 mg of oral hydromorphone daily or an equianalgesic dose of another opioid.)

Allergy to any potential ingredients or medications utilized in any of the two groups

Treatment with another investigational drug or other intervention for pain

Diagnosis of Diabetes Mellitus

If female, pregnant or planning to be pregnant within the following 3 months or study duration

Any condition(s) or diagnosis, both physical or psychological, or physical exam finding in the opinion of the investigator that would precludes participation

What this trial measures

Pain Score VASbaseline, six weeks, and three months
Visual Analogue Scale (VAS) measures pain intensity. The VAS consists of a 10 cm line, with two end points representing 0 ('no pain') and 10 ('pain as bad as it could possibly be'). Pain intensity that is calculated by measuring the distance from the "no pain" end of a line to a mark placed by the patient to indicate their current pain level. This will be measured at baseline, six weeks, and three months.

Trialytics